LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | WZ-4-145 | 0.04 | uM | LJP6 | 1 | J24 | 72 | hr | 1097 | 3127 | 3769 | 0.8295 | 0.7596 |
BT-20 | WZ-4-145 | 0.04 | uM | LJP6 | 2 | J24 | 72 | hr | 1097 | 2808 | 3769 | 0.7449 | 0.6402 |
BT-20 | WZ-4-145 | 0.04 | uM | LJP6 | 3 | J24 | 72 | hr | 1097 | 2596 | 3769 | 0.6887 | 0.5609 |
BT-20 | XMD16-144 | 0.04 | uM | LJP5 | 1 | M12 | 72 | hr | 1097 | 2723 | 3769 | 0.7224 | 0.6084 |
BT-20 | XMD16-144 | 0.04 | uM | LJP5 | 2 | M12 | 72 | hr | 1097 | 2832 | 3769 | 0.7513 | 0.6492 |
BT-20 | XMD16-144 | 0.04 | uM | LJP5 | 3 | M12 | 72 | hr | 1097 | 2436 | 3769 | 0.6462 | 0.5010 |
BT-20 | Brivanib | 0.04 | uM | LJP5 | 1 | P18 | 72 | hr | 1097 | 3511 | 3769 | 0.9314 | 0.9033 |
BT-20 | Brivanib | 0.04 | uM | LJP5 | 2 | P18 | 72 | hr | 1097 | 3682 | 3769 | 0.9768 | 0.9672 |
BT-20 | Brivanib | 0.04 | uM | LJP5 | 3 | P18 | 72 | hr | 1097 | 3535 | 3769 | 0.9378 | 0.9122 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 1 | H06 | 72 | hr | 1097 | 3693 | 3769 | 0.9797 | 0.9714 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 2 | H06 | 72 | hr | 1097 | 4034 | 3769 | 1.0702 | 1.0990 |
BT-20 | Buparlisib | 0.04 | uM | LJP5 | 3 | H06 | 72 | hr | 1097 | 3605 | 3769 | 0.9564 | 0.9384 |
BT-20 | BX-912 | 0.04 | uM | LJP5 | 1 | L24 | 72 | hr | 1097 | 3358 | 3769 | 0.8908 | 0.8460 |
BT-20 | BX-912 | 0.04 | uM | LJP5 | 2 | L24 | 72 | hr | 1097 | 3572 | 3769 | 0.9476 | 0.9261 |
BT-20 | BX-912 | 0.04 | uM | LJP5 | 3 | L24 | 72 | hr | 1097 | 3507 | 3769 | 0.9304 | 0.9018 |
BT-20 | Canertinib | 0.04 | uM | LJP6 | 1 | H12 | 72 | hr | 1097 | 3415 | 3769 | 0.9060 | 0.8673 |
BT-20 | Canertinib | 0.04 | uM | LJP6 | 2 | H12 | 72 | hr | 1097 | 3676 | 3769 | 0.9752 | 0.9650 |
BT-20 | Canertinib | 0.04 | uM | LJP6 | 3 | H12 | 72 | hr | 1097 | 3390 | 3769 | 0.8993 | 0.8580 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 1 | G12 | 72 | hr | 1097 | 4214 | 3769 | 1.1179 | 1.1663 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 2 | G12 | 72 | hr | 1097 | 3869 | 3769 | 1.0264 | 1.0372 |
BT-20 | Celastrol | 0.04 | uM | LJP6 | 3 | G12 | 72 | hr | 1097 | 3835 | 3769 | 1.0174 | 1.0245 |
BT-20 | CGP60474 | 0.04 | uM | LJP5 | 1 | F06 | 72 | hr | 1097 | 3146 | 3769 | 0.8346 | 0.7667 |
BT-20 | CGP60474 | 0.04 | uM | LJP5 | 2 | F06 | 72 | hr | 1097 | 3013 | 3769 | 0.7993 | 0.7169 |
BT-20 | CGP60474 | 0.04 | uM | LJP5 | 3 | F06 | 72 | hr | 1097 | 3002 | 3769 | 0.7964 | 0.7128 |
BT-20 | CGP60474 | 0.04 | uM | LJP6 | 1 | G06 | 72 | hr | 1097 | 679 | 3769 | 0.1801 | -0.1565 |